Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human SMAD2 Antibodies:
anti-Mouse (Murine) SMAD2 Antibodies:
anti-Rat (Rattus) SMAD2 Antibodies:
Go to our pre-filtered search.
Human Monoclonal SMAD2 Primary Antibody for IF, IP - ABIN968106
Babu, Jeganathan, Baker, Wu, Kang-Decker, van Deursen: Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. in The Journal of cell biology 2003
Show all 5 Pubmed References
Human Monoclonal SMAD2 Primary Antibody for IF, IP - ABIN968105
Chen, Waters, Salmon, Murray: Association of spindle assembly checkpoint component XMAD2 with unattached kinetochores. in Science (New York, N.Y.) 1996
Show all 5 Pubmed References
Human Polyclonal SMAD2 Primary Antibody for WB - ABIN2801941
Liu, Pouponnot, Massagué: Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. in Genes & development 1998
Show all 3 Pubmed References
Human Monoclonal SMAD2 Primary Antibody for ICC, FACS - ABIN969401
Wendt, Smith, Schiemann: p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity. in The Journal of biological chemistry 2009
Show all 2 Pubmed References
Human Monoclonal SMAD2 Primary Antibody for IF, IHC (p) - ABIN517619
Talvinen, Tuikkala, Nykänen, Nieminen, Anttinen, Nevalainen, Hurme, Kuopio, Kronqvist: Altered expression of p120catenin predicts poor outcome in invasive breast cancer. in Journal of cancer research and clinical oncology 2010
Human Polyclonal SMAD2 Primary Antibody for ICC, IF - ABIN4354659
Samanta, Gilkes, Chaturvedi, Xiang, Semenza: Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. in Proceedings of the National Academy of Sciences of the United States of America 2014
Chicken Polyclonal SMAD2 Primary Antibody for IHC (p), WB - ABIN4354661
Xu, Xue, Li, Bi, Cao: Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. in Journal of virology 2010
Human Polyclonal SMAD2 Primary Antibody for IHC, IHC (p) - ABIN4354665
Yamamura, Matsumura, Mandai, Huang, Oura, Baba, Hamanishi, Yamaguchi, Kang, Okamoto, Abiko, Mori, Murphy, Konishi: The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. in International journal of cancer 2011
Human Monoclonal SMAD2 Primary Antibody for FACS, IF - ABIN967045
Hannan, Jamshidi, Pera, Wolvetang: BMP-11 and myostatin support undifferentiated growth of human embryonic stem cells in feeder-free cultures. in Cloning and stem cells 2009
Show all 2 Pubmed References
Human Polyclonal SMAD2 Primary Antibody for WB - ABIN362416
Kim, Jong, Kim, Lee, Kim, Hong, Bang: Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells. in Molecular biology of the cell 2004
Show all 2 Pubmed References
The non-Smad (show SMAD1 Antibodies) JNK (show MAPK8 Antibodies) signaling pathway, which is downstream of Nodal signaling, regulates nuclear movement independently of the Smad (show SMAD1 Antibodies) pathway, and this nuclear movement is associated with Smad (show SMAD1 Antibodies) signal transduction toward the nucleus.
The results of this study found that Bptf (show BPTF Antibodies) and TGF-beta (show TGFB1 Antibodies)/Smad2 mediate nucleosome remodeling to regulate wnt8a (show WNT8A Antibodies) expression and hence neural posteriorization.
Smad2 and Eomesodermin (show EOMES Antibodies) a (Eomesa (show EOMES Antibodies)) bind common genomic regions proximal to genes involved in mesoderm and endoderm formation, suggesting Eomesa (show EOMES Antibodies) forms a general component of the Smad2 signalling complex in zebrafish.
These results reveal that kinesin-mediated transport of Smad2 along microtubules to the receptors is an essential step in ligand-induced Smad2 activation.
study systemically uncovers a large number of Smad2 targets in early gastrulas and suggests cooperative roles of Smad2 and other transcription factors in controlling target gene transcription
Nodal signaling and mesendoderm induction depend on Smad2/3 and suggest that transforming growth factor-beta signals other than Nodal also contribute to Smad2/3 signaling and embryonic patterning.
Smad2/3 activities play important roles not only in mesendodermal development but also in neural development during early vertebrate embryogenesis
a novel heterozygous missense mutation (c.833C>T, p.A278V) in the SMAD2 gene in a family with early onset aortic aneurysms
Data suggest that oncogenic Y-box binding protein 1 (YB-1 (show YBX1 Antibodies)) indirectly enhances transforming growth factor beta (TGFbeta (show TGFB1 Antibodies)) signaling cascades via Sma (show SMN1 Antibodies)/Mad related protein 2 (Smad2)phospho-activation and may represent a promising factor for future diagnosis and therapy of breast cancer.
Asiaticoside hindered the invasive growth of KFs (show GDF6 Antibodies) by inhibiting the GDF-9 (show GDF9 Antibodies)/MAPK (show MAPK1 Antibodies)/Smad (show SMAD1 Antibodies) pathway.
High Smad2 expression is associated with invasion and metastasis in pancreatic ductal adenocarcinoma.
Data indicate that miR (show MLXIP Antibodies)-206 inhibits neuropilin-1 (NRP1 (show NRP1 Antibodies)) and SMAD2 gene expression by directly binding to their 3'-UTRs.
Results show that members of the Activin (show Actbeta Antibodies) branch of the TGFbeta (show TGFB1 Antibodies) signaling pathway, namely Put and Smad2, are autonomously required for cell and tissue growth in the Drosophila larval salivary gland.
CytoD modified MKL1, a coactivator of serum response factor (SRF) regulating CTGF induction, and promoted its nuclear localization.
cells expressing mutant huntingtin (show HTT Antibodies) have a dysregulated transcriptional response to epidermal growth factor (show EGF Antibodies) stimulation
CRT (show SLC6A8 Antibodies) regulates TGF-beta1 (show TGFB1 Antibodies)-induced-EMT (show ITK Antibodies) through modulating Smad (show SMAD1 Antibodies) signaling
P311 (show C5orf13 Antibodies) is a novel TGFbeta1 (show TGFB1 Antibodies)/Smad (show SMAD1 Antibodies) signaling-mediated regulator of transdifferentiation in epidermal stem cells during cutaneous wound healing.
Grg4 (show TLE4 Antibodies) occupancy at the Xnr1 (show NODAL Antibodies) enhancer significantly decreases with Smad2 overexpression.Nodal-activated Smad2 physically displaces Grg4 (show TLE4 Antibodies) from FoxH1 (show FOXH1 Antibodies) at the Xnr1 (show NODAL Antibodies) enhancer, an essential feature of the transcriptional switch mechanism.
E2a (show TCF3 Antibodies) is necessary to drive transcription of Smad2/3 target genes, including critical regulators of dorsal cell fate and morphogenesis
GDF11 (show GDF11 Antibodies) has a central role in the activation of Smad2 phosphorylation in tailbud stage Xenopus embryos.
XPIASy functions as an essential negative regulator of the XSmad2 pathway to ensure proper mesoderm induction at the appropriate time and in the appropriate region.
Activin A (show INHBA Antibodies) and overexpression of SMAD2/3 significantly promoted expressions of porcine NANOG (show NANOG Antibodies) and OCT4 (show POU5F1 Antibodies),maintaining induced pluripotent stem cell self-renewal through up-regulation of Nanog (show NANOG Antibodies)/OCT4 (show POU5F1 Antibodies) expression.
the present work provides evidence supporting a functional role of SMAD2/3 in bovine early embryogenesis
Mechanical compression not only with physiological but also with excessive stress can activate Smad2/3P signaling, which is known to be protective for articular cartilage and to block chondrocyte terminal differentiation.
a detailed computational model for TGF-beta (show TGFB1 Antibodies) signalling that incorporates elements of previous models together with crosstalking between Smad1 (show SMAD1 Antibodies)/5/8 and Smad2/3 channels through a negative feedback loop dependent on Smad7 (show SMAD7 Antibodies).
NODAL/Activin (show Actbeta Antibodies) signaling induces dramatic chromatin landscape changes, and a dynamic transcriptional network regulated by SMAD2, acting via multiple mechanisms.
Blocking Smad2/3 signaling in pluripotent stem cells results in epigenetic changes that enhance the capacity for endoderm differentiation.
Smad2- and Smad3 (show SMAD3 Antibodies)-deficient bone marrow (BM) cells display reduced sensitivity to transforming growth factor-beta (TGFbeta (show TGFB1 Antibodies)) inhibition.
Data (including data from studies using knockout mice) suggest Garp/Lrrc32 (show LRRC32 Antibodies) is involved in up-regulation of Tgfb3 (show TGFB3 Antibodies) and is essential for embryogenesis of palate; Garp (show LRRC32 Antibodies) knockout causes postnatal lethality, cleft palate, and decreased apoptosis and Smad2 phosphorylation in medial edge epithelial cells of palatal shelf of embryos. (Garp (show LRRC32 Antibodies) = glycoprotein A repetitions predominant (show LRRC32 Antibodies) protein; Tgfb3 (show TGFB3 Antibodies) = transforming growth factor beta 3 (show TGFB3 Antibodies))
This study tested the hypothesis that inhibins act in an autocrine manner on Leydig cells using a pre-pubertal Leydig cell line, TM3 (show TPM1 Antibodies), as a model of immature Leydig cells.
Lnc-LFAR1 binds directly to Smad2/3 and promotes transcription of TGFbeta (show TGFB1 Antibodies), Smad2, Smad3 (show SMAD3 Antibodies), Notch2 (show NOTCH2 Antibodies) and Notch3 (show NOTCH3 Antibodies) which, in turn, results in TGFbeta (show TGFB1 Antibodies) and Notch (show NOTCH1 Antibodies) pathway activation.
the levels of Smad2/3, P-Smad2/3 expressions were decreased, while the level of Smad7 (show SMAD7 Antibodies) expression was increased after treatment with osthole.
These findings implicate TGF-beta (show TGFB1 Antibodies)-Smad2/3 signaling in activated tissue-resident cardiac fibroblasts as principal mediators of the fibrotic response.
The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene.
SMAD, mothers against DPP homolog 2
, MAD (mothers against decapentaplegic, Drosophila) homolog 2
, SMA- and MAD-related protein 2
, SMAD 2
, SMAD family member 2
, mothers against DPP homolog 2
, mothers against decapentaplegic homolog 2
, MAD homolog 2
, Sma- and Mad-related protein 2
, mother against DPP homolog 2
, mothers against decapentaplegic-like 2
, Smad 2
, mad-related protein 2